close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

< Previous 1 2 3 Next >
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags Science Health & Science Health care industry
From CNBC.com News
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
Tags Breaking News: Earnings Health care industry Health & Science
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags Health care industry Health & Science Novo Nordisk A/S
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Pharmaceuticals Business News Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Health care industry Health & Science Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Markets Walt Disney Co General Motors Co
From CNBC.com News
Reid Hoffman enters 'wondrous and terrifying' world of health care with latest AI startup
Tags LILLY DRN AI / Artificial Intelligence Airbnb Inc
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Amazon/com Inc Bristol/Myers Squibb Co Chipotle Mexican Grill Inc
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Pharmaceuticals Companies Health care industry
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Novo Nordisk A/S LILLY DRN Elevance Health Inc
From CNBC.com News
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Tags Business News GSK plc Biotechnology
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags Novo Nordisk A/S Breaking News: Davos LILLY DRN
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Health & Science Hospitals Health care industry
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Health & Science Pharmaceuticals Social issues
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Business News Bristol/Myers Squibb Co Eisai Co Ltd
From CNBC.com News
Jim Cramer says he supports healthcare stocks for their long-term value
Tags Stock markets Merck & Co Inc U/S/ Markets
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Healthy Returns Madrigal Pharmaceuticals Inc Dexcom Inc
From CNBC.com News
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
Tags Business News Earnings Breaking News: Business
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Health & Science Health care industry Breaking News: Business
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Health & Science Labor economy Health care industry
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags US: News LILLY DRN Novo Nordisk A/S
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags Merck & Co Inc Pfizer Inc Accolade Inc
From CNBC.com News
Cramer's Lightning Round: Uber is a buy
Tags Uber Technologies Inc Mad Money stocks
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Health care industry Health & Science Health care costs
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Business News Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Friday
Tags Politics Nike Inc Investment strategy
From CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
Tags Breaking news Social issues Pharmaceuticals
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags LILLY DRN Social issues Novo Nordisk A/S
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Companies Pharmaceuticals Health & Science
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Cybersecurity Weight management Technology
From CNBC.com News
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.